Literature DB >> 10342388

Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population.

T L Moore1, R Bandlamudi, S M Alam, G Nesher.   

Abstract

OBJECTIVES: To assess the striking similarities of presentation in a pediatric population between human parvovirus B19 (HPV-B19) infection and systemic lupus erythematous (SLE).
METHODS: Medical records of seven patients (ages 6 to 15) with HPV-B19 infection were reviewed retrospectively.
RESULTS: Six of seven cases presented with a history of malar rash, and all seven had prolonged arthralgias and fatigue. Six of seven had a positive antinuclear antibody (ANA) titer ranging from 1:40 to greater than 1:640, with two patients having antibodies to Scl-70 and others to Sm, RNP, SS-A (Ro), or SS-B (La). The erythrocyte sedimentation rate (ESR) varied from 2 to 68 mm/h. Two patients presented with elevated rheumatoid factor (RF) titers of 24 and 271 IU/mL, respectively. All had elevated IgM antibody levels to parvovirus at the onset, and markedly elevated IgG levels when evaluated throughout their disease course. Over the course of 2 to 3 months, three improved, but the other four continued to have symptomatology for 14, 40, 78, and 120 weeks, respectively. Treatment was symptomatic, and no one developed classic SLE.
CONCLUSIONS: HPV-B19 infection in a pediatric patient group may present with SLE-like symptomatology and positive serology suggestive of SLE. The course of the disease is usually self-limited, though it may be prolonged in some for up to 120 weeks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342388     DOI: 10.1016/s0049-0172(99)80015-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  10 in total

1.  Familial collapsing focal segmental glomerulosclerosis.

Authors:  V Liakopoulos; A Huerta; S Cohen; M R Pollak; R A Sirota; K Superdock; G B Appel
Journal:  Clin Nephrol       Date:  2011-04       Impact factor: 0.975

2.  The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.

Authors:  Simone Dorsch; Gerhard Liebisch; Bärbel Kaufmann; Philipp von Landenberg; Jörg H Hoffmann; Wolfgang Drobnik; Susanne Modrow
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  A One-Year-Old Girl With Human Parvovirus B19 Infection and Hypocomplementemia Mimicking Incomplete Kawasaki Disease.

Authors:  Kazumi Oura; Shinichi Ishikawa; Haruki Shiraishi; Yuji Maruo; Norio Sato; Takashi Suganuma; Makoto Mikawa; Tomonobu Sato
Journal:  J Med Cases       Date:  2022-04-23

5.  Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.

Authors:  T-C Hsu; B-S Tzang; C-N Huang; Y-J Lee; G-Y Liu; M-C Chen; G J Tsay
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 6.  Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit?

Authors:  Marianne C Severin; Yair Levy; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

7.  Parvovirus B19 infection mimicking systemic lupus erythematosus, successfully treated with intravenous immune globulin.

Authors:  Sare Gülfem Özlü; Başak Alan; Aysegül Şahiner; Büşra Bulut; Gülsüm İclal Bayhan; Sonay İncesoy Özdemir
Journal:  Germs       Date:  2020-09-01

8.  The putative metal coordination motif in the endonuclease domain of human Parvovirus B19 NS1 is critical for NS1 induced S phase arrest and DNA damage.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Biol Sci       Date:  2011-11-24       Impact factor: 6.580

Review 9.  Approach to a patient with connective tissue disease.

Authors:  T Sathish Kumar; Amita Aggarwal
Journal:  Indian J Pediatr       Date:  2010-10-06       Impact factor: 5.319

10.  Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.

Authors:  Milda Naciute; Diana Mieliauskaite; Rita Rugiene; Rita Nikitenkiene; Ligita Jancoriene; Mykolas Mauricas; Zaiga Nora-Krukle; Modra Murovska; Irute Girkontaite
Journal:  J Gen Virol       Date:  2016-10-07       Impact factor: 3.891

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.